Abbott Laboratories (ABT)

Interest coverage

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 8,666,000 8,471,000 7,975,000 7,616,000 7,464,000 7,177,000 7,191,000 7,362,000 6,816,000 6,811,000 7,459,000 8,621,000 9,553,000 10,351,000 9,398,000 8,621,000 8,707,000 7,642,000 6,845,000 5,676,000
Interest expense (ttm) US$ in thousands 451,000 573,000 620,000 603,000 686,000 668,000 653,000 698,000 627,000 535,000 467,000 315,000 240,000 303,000 354,000 410,000 435,000 442,000 467,000 708,000
Interest coverage 19.22 14.78 12.86 12.63 10.88 10.74 11.01 10.55 10.87 12.73 15.97 27.37 39.80 34.16 26.55 21.03 20.02 17.29 14.66 8.02

September 30, 2025 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $8,666,000K ÷ $451,000K
= 19.22


Peer comparison

Sep 30, 2025

Company name
Symbol
Interest coverage
Abbott Laboratories
ABT
19.22
CONMED Corporation
CNMD
3.63
Stryker Corporation
SYK
14.24

See also:

Abbott Laboratories Interest Coverage (Quarterly Data)